Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;39(2):130-8.
doi: 10.1016/j.bj.2015.07.001. Epub 2016 Jun 10.

Risk factors of multidrug-resistant Acinetobacter baumannii recurrence after successful eradication in ventilated patients

Affiliations

Risk factors of multidrug-resistant Acinetobacter baumannii recurrence after successful eradication in ventilated patients

Chiung-Yu Lin et al. Biomed J. 2016 Apr.

Abstract

Background: Clinically, multidrug-resistant Acinetobacter baumannii (MDR-AB) recurrence is found in some patients although identified as successfully eradicated. We aim to discover the characteristics of patients with MDR-AB recurrence in the respiratory tract.

Methods: We retrospectively collected 106 chronic respiratory failure patients with MDR-AB harvest in pulmonary secretion culture.

Results: MDR-AB was successfully eradicated in 69 patients. Diabetes mellitus (p = 0.030, odds ratio [OR]: 2.7, 95% confidence interval [CI]: 1.1-6.4) and acute respiratory distress syndrome (p = 0.001, OR = 4.8, 95% CI: 1.8-12.7) reduce the MDR-AB eradication rate. Besides, a classification of colonization or infection was made beyond the 69 MDR-AB eradicated patients. In the colonization group, diabetes mellitus (p = 0.009; OR = 5.1, 95% CI: 1.5-17.6) is the only independent factor to increase the recurrence rate. Glycated hemoglobin level is also analyzed for each group to investigate diabetes control effect, but no significant difference found.

Conclusions: Diabetes mellitus is a risk factor of MDR-AB recurrence among MDR-AB-colonized patients; the impact of localized pneumonia patch in MDR-AB-infected patients requires further study to be clarified.

Keywords: Chronic respiratory failure; Multidrug-resistant Acinetobacter baumannii; Recurrence; Risk factor.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Multidrug-resistant Acinetobacter baumannii was successfully eradicated in 69 patients and a categorization is made on these patients into colonization or infection group.

References

    1. Villegas M.V., Hartstein A.I. Acinetobacter outbreaks, 1977–2000. Infect Control Hosp Epidemiol. 2003;24:284–295. - PubMed
    1. Wendt C., Dietze B., Dietz E., Rüden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol. 1997;35:1394–1397. - PMC - PubMed
    1. Hirai Y. Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection. J Hosp Infect. 1991;19:191–200. - PubMed
    1. Perez F., Hujer A.M., Hujer K.M., Decker B.K., Rather P.N., Bonomo R.A. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51:3471–3484. - PMC - PubMed
    1. Seifert H., Boullion B., Schulze A., Pulverer G. Plasmid DNA profiles of Acinetobacter baumannii: clinical application in a complex endemic setting. Infect Control Hosp Epidemiol. 1994;15:520–528. - PubMed

Substances